Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1660

1.

Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.

Szilagyi PG, Fairbrother G, Griffin MR, Hornung RW, Donauer S, Morrow A, Altaye M, Zhu Y, Ambrose S, Edwards KM, Poehling KA, Lofthus G, Holloway M, Finelli L, Iwane M, Staat MA; New Vaccine Surveillance Network..

Arch Pediatr Adolesc Med. 2008 Oct;162(10):943-51. doi: 10.1001/archpedi.162.10.943.

PMID:
18838647
2.

Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):393-8.

3.

Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants.

Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D; Vaccine Safety Datalink Workgroup..

Am J Perinatol. 2004 Aug;21(6):333-9.

PMID:
15311370
4.

Incidence of outpatient visits and hospitalizations related to influenza in infants and young children.

O'Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A, Yu XJ, Platt R, Lieu TA.

Pediatrics. 2004 Mar;113(3 Pt 1):585-93.

PMID:
14993554
5.

Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study.

Joshi AY, Iyer VN, St Sauver JL, Jacobson RM, Boyce TG.

Vaccine. 2009 Jul 16;27(33):4457-61. doi: 10.1016/j.vaccine.2009.05.038.

PMID:
19490957
6.

The burden of influenza illness in children with asthma and other chronic medical conditions.

Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR.

J Pediatr. 2000 Dec;137(6):856-64.

PMID:
11113844
7.

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.

Herrera GA, Iwane MK, Cortese M, Brown C, Gershman K, Shupe A, Averhoff F, Chaves SS, Gargiullo P, Bridges CB.

Vaccine. 2007 Jan 2;25(1):154-60. Erratum in: Vaccine. 2008 Jul 29;26(32):4101-3.

PMID:
17064823
8.

Influenza burden for children with asthma.

Miller EK, Griffin MR, Edwards KM, Weinberg GA, Szilagyi PG, Staat MA, Iwane MK, Zhu Y, Hall CB, Fairbrother G, Seither R, Erdman D, Lu P, Poehling KA; New Vaccine Surveillance Network..

Pediatrics. 2008 Jan;121(1):1-8. doi: 10.1542/peds.2007-1053.

PMID:
18166550
9.

Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.

Salleras L, DomĂ­nguez A, Pumarola T, Prat A, Marcos MA, Garrido P, Artigas R, Bau A, Brotons J, Bruna X, CatalĂ  P, Carreras E, Cuadra D, Gatell A, Millet S, Oller J, Raga E.

Vaccine. 2006 Nov 10;24(44-46):6638-42.

PMID:
16842892
10.

Effectiveness of influenza vaccine in the elderly.

Nichol KL, Margolis KL, Wouremna J, von Sternberg T.

Gerontology. 1996;42(5):274-9.

PMID:
8940650
11.

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group..

J Infect Dis. 2009 Jan 15;199(2):159-67. doi: 10.1086/595861.

12.

Potential burden of universal influenza vaccination of young children on visits to primary care practices.

Szilagyi PG, Iwane MK, Schaffer S, Humiston SG, Barth R, McInerny T, Shone L, Schwartz B.

Pediatrics. 2003 Oct;112(4):821-8.

PMID:
14523173
13.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

14.

Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season.

Allison MA, Daley MF, Crane LA, Barrow J, Beaty BL, Allred N, Berman S, Kempe A.

J Pediatr. 2006 Dec;149(6):755-762.

PMID:
17137887
15.

Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004.

Shuler CM, Iwamoto M, Bridges CB, Marin M, Neeman R, Gargiullo P, Yoder TA, Keyserling HL, Terebuh PD.

Pediatrics. 2007 Mar;119(3):e587-95.

PMID:
17332179
16.

Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.

American Academy of Pediatrics Committee on Infectious Diseases..

Pediatrics. 2008 Apr;121(4):e1016-31. doi: 10.1542/peds.2008-0160. Review.

PMID:
18381500
17.

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.

Vaccine. 2008 Jun 2;26(23):2841-8. doi: 10.1016/j.vaccine.2008.03.046.

PMID:
18462851
18.
19.

Influenza vaccine effectiveness in primary school children in Japan: a prospective cohort study using rapid diagnostic test results.

Yamaguchi S, Ohfuji S, Hirota Y.

J Infect Chemother. 2010 Dec;16(6):407-13. doi: 10.1007/s10156-010-0070-8.

PMID:
20490595
20.

Impact of influenza on young children and the shaping of United States influenza vaccine policy.

Terebuh P, Uyeki T, Fukuda K.

Pediatr Infect Dis J. 2003 Oct;22(10 Suppl):S231-5. Review. Erratum in: Pediatr Infect Dis J. 2004 Apr;23(4):294.

PMID:
14551482
Items per page

Supplemental Content

Support Center